News

NeuraSignal’s NovaGuide™ Intelligent Ultrasound System Significantly Outperforms Standard of Care for Detecting Stroke-Associated Heart Defects

—Data published in Stroke show that NovaGuide was about three times more likely to detect right to left shunt (RLS)…

2 years ago

Carmot Therapeutics Announces that Preliminary Phase 1 Results Support Once-daily Oral Dosing for its Obesity and Type 2 Diabetes Candidate CT-996

BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing…

2 years ago

Vision Sensing Acquisition Corp. Announces Intention to Transfer All Trust Funds Into an Interest-Bearing Demand Deposit Account

MIAMI, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”), a special purpose…

2 years ago

Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions

BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical…

2 years ago

Envoy Medical Announces Settlement Contract

Outstanding Shareholder Claims ResolvedWHITE BEAR LAKE, Minn., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (NASDAQ: COCH), a hearing…

2 years ago

SS Innovations Receives Regulatory Approvals from the Guatemala Ministry of Health

The Mantra Surgical Robotic System has been given the approval to be used for clinical use in Guatemala, marking the…

2 years ago

Safety Shot’s Chief Operating Officer Jarrett Boon Joins Company’s Board of Directors

JUPITER, FL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) today announced that Jarrett Boon, who has…

2 years ago

American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed’s MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea

-- Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S.CAMBRIDGE, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) --…

2 years ago

Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health

DUBLIN, Ireland, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer…

2 years ago